Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Dementia specialists face overwhelming demand and insufficient staffing, creating wait times that can stretch across years. In the UK, patients wait an average of 3.5 years from their first symptoms to receiving a diagnosis, with nearly 6 months of that wait occurring after referral to a memory clinic. One in five people wait more than 2 years for diagnosis after visiting their GP. This isn’t a problem limited to one region—across North America and Europe, the story is similar. The United States faces a documented shortage of approximately 18,000 neurologists, with 41 states reporting critical staffing gaps.
These delays aren’t simply inconvenient; they mean people live with uncertainty while their condition progresses, caregivers remain without a diagnosis to guide their care, and early intervention opportunities may be missed. The reasons for these long waits are systemic, not accidental. A 26-year freeze on Medicare-funded medical residency positions—dating back to 1997’s Balanced Budget Act—has capped training slots at 1996 levels, even as medical school graduates increased and the population aged dramatically. Simultaneously, neurologists report burnout at unprecedented rates, with 65% experiencing burnout or depression. The aging of the population has accelerated demand: Americans aged 65 and older are projected to increase 42% between 2022 and 2050. When supply is frozen and demand skyrockets, waiting lists become inevitable.
Table of Contents
- How Long Are Dementia Specialist Wait Times in Different Regions?
- Why Aren’t There Enough Dementia Specialists?
- How Does Aging Population Increase Demand for Dementia Care?
- Why Are Rural and Remote Areas Particularly Affected?
- What Role Does Neurologist Burnout Play in Wait Times?
- How Does the Medicare Funding Freeze Limit Training Capacity?
- What Initiatives Are Beginning to Address Long Wait Times?
How Long Are Dementia Specialist Wait Times in Different Regions?
Wait times vary significantly by geography, but they are long everywhere. In the United Kingdom, the Alzheimer’s Society reported in October 2025 that patients wait an average of 17.7 weeks for dementia diagnosis after referral. However, this figure masks a larger problem: the 22-week average wait after referral is just one piece of a much longer journey. A quarter of patients wait more than 2 years for diagnosis after first visiting their general practitioner. Nearly 75% of UK GPs report long wait times for specialist assessment, indicating the problem originates not just in specialist clinics but throughout the diagnostic pathway.
In Canada, the wait times are comparable or worse. Patients in Ontario wait up to 2 years for specialist dementia assessment, a timeframe that reflects the same supply-demand mismatch seen elsewhere. In the United States, while general neurology wait times average 34 days, this masks significant variation—18% of patients wait longer than 90 days, and dementia patients tend to fall into the longer-wait category. Rural Americans face particular challenges: 71% of rural physicians report insufficient dementia specialists in their regions, compared to 44% of urban physicians. These disparities mean that geography itself determines whether someone receives prompt evaluation or faces years of waiting.
Why Aren’t There Enough Dementia Specialists?
The shortage of neurologists is both acute and measurable. The United States currently has an estimated gap of 19% in neurologist staffing nationwide. Translated to concrete numbers, demand is projected at 21,440 neurologists, but supply only reaches approximately 18,060 by 2025—a shortfall of roughly 18,000 specialists. Forty-one states face neurologist shortages, and in most of these states, the gap exceeds 20% of needed staff. This isn’t a minor imbalance that can be corrected through recruitment alone; it represents a structural failure in the training pipeline.
One critical factor is the medicare training freeze. Since 1997, the number of federally funded medical residency positions has been capped, regardless of population growth or specialization demand. While medical schools expanded and more graduates entered the field, the number of funded training slots remained static for 26 years. Neurology, a field critical to dementia care, didn’t receive proportional increases in training capacity. This policy constraint means that even highly motivated physicians cannot access residency training in numbers sufficient to meet population need. The policy is beginning to shift—there has been some movement toward increasing residency slots—but the effects will take years to materialize in clinical practice.
How Does Aging Population Increase Demand for Dementia Care?
The fundamental driver behind waitlist growth is demographic: America is aging rapidly. Census data shows the population aged 65 and older will increase 42% between 2022 and 2050. This age group bears the highest burden of dementia. Alzheimer’s disease affects roughly 1 in 9 people aged 65 and older, and prevalence increases steeply with age. As the population cohort in their 75s, 80s, and 90s expands, the number of people requiring dementia diagnosis and specialist management grows exponentially.
Current specialist capacity, already insufficient, becomes ever more inadequate. The demand surge extends beyond diagnostics to ongoing management. Neurologists specializing in dementia manage not just Alzheimer’s disease but Parkinson’s disease, Lewy body dementia, frontotemporal dementia, vascular dementia, and other neurodegenerative conditions. All of these conditions are becoming more common as the population ages. Texas alone projects a 30.5% increase in demand for home health and personal care aides by 2030—a sign that the entire ecosystem of dementia care is straining. Specialists aren’t just overbooked; they’re managing patients whose illnesses are progressing faster than the system can deliver care.
Why Are Rural and Remote Areas Particularly Affected?
Geographic inequality is a defining feature of the specialist shortage. In rural America, access to neurologists is severely limited. Nearly 71% of rural physicians report insufficient dementia specialists in their geographic area, compared to 44% in urban regions. This means rural patients don’t simply wait longer for appointments in their towns; many face the additional burden of traveling significant distances for care. Medicare data shows that 17% of Medicare neurologist visits required patients to travel an average of 81 miles one way.
For an elderly patient with cognitive decline or a spouse serving as caregiver, an 81-mile round trip to see a specialist represents a substantial logistical and financial barrier. Telemedicine has offered some relief, but it cannot solve the fundamental problem. Rural specialists are fewer in number, so even virtual appointments with distant providers involve longer wait times. Additionally, many diagnostic procedures for dementia—neuropsychological testing, advanced imaging interpretation, lumbar punctures for cerebrospinal fluid biomarkers—require in-person interaction. A patient in a remote area may wait months for a telemedicine consultation, then wait additional months for referral to an in-person specialist for confirmatory testing. The result is that rural patients experience the cumulative effect of all these bottlenecks.
What Role Does Neurologist Burnout Play in Wait Times?
Burnout among neurologists has reached crisis proportions and directly contributes to shorter clinic hours, reduced availability, and premature workforce exit. Survey data from 2025 shows 65% of neurologists report burnout or depression. This extraordinarily high rate reflects not just heavy workload but also administrative burden, prior authorization requirements, electronic health record demands, and the emotional weight of managing progressive illnesses with limited curative options. When a specialist reaches burnout, they may reduce their practice hours, retire early, or shift to non-clinical roles. Each of these decisions reduces the capacity of the remaining pool of specialists. The post-COVID period accelerated this trend.
Many healthcare workers, including neurologists, experienced staffing crises during the pandemic and burnout reached fever pitch. Some chose to leave clinical practice entirely. The pandemic also disrupted specialty training; some residency programs lost educational capacity. As neurologists leave the field faster than new ones complete training, wait times continue to extend. This creates a vicious cycle: longer wait lists make remaining specialists more overbooked, which increases burnout, which drives more specialists away. The result is that wait times now exceed what the static number of neurologists might suggest—specialists are operating at diminished capacity.
How Does the Medicare Funding Freeze Limit Training Capacity?
The Balanced Budget Act of 1997 implemented a 26-year freeze on federally funded medical residency positions. This policy was designed to control healthcare costs, but it had an unintended consequence: it created a structural cap on physician training that persisted long after circumstances changed. Between 1997 and 2023, the cap remained essentially static, while medical school enrollment grew and population aging created new demand for specialties like neurology, geriatric medicine, and psychiatry. The policy meant that even as the medical profession recognized the need for more neurologists, there were no additional residency slots to train them.
In recent years, policymakers have begun to increase training positions, but the effects are slow to manifest. A new residency position creates a neurologist only after 4 years of residency training, and newly trained neurologists need time to establish practices. The 26-year freeze thus created a decade or more of delayed supply response. Some states have received federal funding for additional residency positions, and medical schools have taken on more residents in their existing slots, but the capacity increase remains insufficient to address the full shortage estimated at 18,000 neurologists.
What Initiatives Are Beginning to Address Long Wait Times?
Several initiatives are attempting to reduce dementia diagnostic delays. The Centers for Medicare & Medicaid Services launched the GUIDE Model on July 1, 2024, as an 8-year pilot program designed to improve dementia care. As of 2025, 330 of the 390 approved programs are operating, offering comprehensive dementia services including diagnostic support, management, caregiver education, and behavioral health integration. These programs aim to reduce wait times by distributing the diagnostic burden across teams rather than relying solely on neurologist specialists.
Early results suggest this distributed model can improve access, though participation remains limited. In the UK, NHS England reported in December 2025 that 66.3% of estimated dementia cases in people aged 65 and older have been diagnosed—an improvement but still indicating nearly one in three cases remain undiagnosed. Minnesota invested nearly $750,000 in 2025-2026 grants to seven organizations focused on early diagnosis promotion and reducing barriers to specialist access. These initiatives suggest recognition that wait times require multifaceted solutions: not just training more specialists, but also training other clinicians in basic dementia evaluation, using team-based approaches, and improving the efficiency of diagnostic pathways.
- —
